- Home
- MNKD vs PGNY Comparison
MNKD vs PGNY Comparison
Compare MNKD & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNKD | PGNY |
|---|---|---|
| Founded | 1991 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Misc Health and Biotechnology Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2004 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MNKD | PGNY |
|---|---|---|
| Price | $5.95 | $24.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 10 |
| Target Price | $10.08 | ★ $27.90 |
| AVG Volume (30 Days) | ★ 3.5M | 1.4M |
| Earning Date | 02-25-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.47 | 2.96 |
| EPS | 0.10 | ★ 0.62 |
| Revenue | $313,787,000.00 | ★ $1,268,689,000.00 |
| Revenue This Year | $21.40 | $11.63 |
| Revenue Next Year | $25.03 | $9.52 |
| P/E Ratio | $58.33 | ★ $41.23 |
| Revenue Growth | ★ 17.43 | 11.41 |
| 52 Week Low | $3.38 | $17.98 |
| 52 Week High | $6.51 | $28.75 |
Technical Indicators
Market Signals| Indicator | MNKD | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 57.73 | 45.74 |
| Support Level | $5.03 | $24.10 |
| Resistance Level | $5.68 | $25.78 |
| Average True Range (ATR) | 0.27 | 1.20 |
| MACD | -0.01 | -0.26 |
| Stochastic Oscillator | 61.15 | 17.53 |
Price Performance
Historical ComparisonAbout MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About PGNY Progyny Inc.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.